Mhy-Lanie Adduru

Mhy-Lanie Adduru, MD, currently serves as the Chief Medical Officer at Predictiv since July 2020, where leadership focuses on the development of DNA-based digital twin technology to enhance disease prediction and prevention. In addition to serving as Co-CEO, Mhy-Lanie has expanded operations in the UAE and promoted public understanding of genetics. Mhy-Lanie's previous roles include Chief Analytics Officer at ZtoMed, where patient genomics data analysis was prioritized, and a post-doctorate position at Ochsner Health centered on research related to multi-drug resistant bacteria. Mhy-Lanie co-founded Immidee Technologies, offering case management for the immigration legal sector, and worked as a Senior Case Manager in business immigration. Education includes a Master of Science in Biotechnology from The Johns Hopkins University, an MD from Ochsner Clinical School, another MD from The University of Queensland, and a Bachelor of Arts in Physical and Biological Anthropology from the University of California, Berkeley. Mhy-Lanie also serves as a mentor for Stanford University's Master of Science in Clinical Informatics Management program.